$RHHBY News Article - Genentech's Tecentriq Plus Avastin Is the First Treatment Combination to Reduce the Risk of Cancer Returning in People With Certain Types of Early-Stage Liver Cancer in a Phase III Trial
https://marketwirenews.com/news-releases/gene...41949.html